Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Lipocrinology - the relationship between lipids and endocrine function.

Kalra S, Priya G.

Drugs Context. 2018 Jan 31;7:212514. doi: 10.7573/dic.212514. eCollection 2018.

2.

Statin-prescribing trends for primary and secondary prevention of cardiovascular disease.

Brown F, Singer A, Katz A, Konrad G.

Can Fam Physician. 2017 Nov;63(11):e495-e503. Epub 2017 Nov 14.

3.

Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat ╬▓-Cells. Direct Effect of Oxidative Stress.

Urbano F, Bugliani M, Filippello A, Scamporrino A, Di Mauro S, Di Pino A, Scicali R, Noto D, Rabuazzo AM, Averna M, Marchetti P, Purrello F, Piro S.

Sci Rep. 2017 Sep 19;7(1):11863. doi: 10.1038/s41598-017-11070-x.

4.

Pilot Algorithm Designed to Help Early Detection of HMG-CoA Reductase Inhibitor-Induced Hepatotoxicity.

Hong JY, Kim HS, Choi IY.

Healthc Inform Res. 2017 Jul;23(3):199-207. doi: 10.4258/hir.2017.23.3.199. Epub 2017 Jul 31.

5.

Hypocholesterolemic Effects of Probiotic Mixture on Diet-Induced Hypercholesterolemic Rats.

Kim SJ, Park SH, Sin HS, Jang SH, Lee SW, Kim SY, Kwon B, Yu KY, Kim SY, Yang DK.

Nutrients. 2017 Mar 16;9(3). pii: E293. doi: 10.3390/nu9030293.

6.

Pleiotropic effects of statins in the perioperative setting.

Galyfos G, Sianou A, Filis K.

Ann Card Anaesth. 2017 Jan;20(Supplement):S43-S48. doi: 10.4103/0971-9784.197796. Review.

7.

Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis.

Pinkosky SL, Newton RS, Day EA, Ford RJ, Lhotak S, Austin RC, Birch CM, Smith BK, Filippov S, Groot PH, Steinberg GR, Lalwani ND.

Nat Commun. 2016 Nov 28;7:13457. doi: 10.1038/ncomms13457.

8.

Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics.

Leonard CE, Brensinger CM, Bilker WB, Kimmel SE, Han X, Nam YH, Gagne JJ, Mangaali MJ, Hennessy S.

Int J Cardiol. 2017 Feb 1;228:761-770. doi: 10.1016/j.ijcard.2016.11.245. Epub 2016 Nov 12.

9.

Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.

Yoon D, Sheen SS, Lee S, Choi YJ, Park RW, Lim HS.

Medicine (Baltimore). 2016 Nov;95(46):e5429.

10.

Pregabalin- and azithromycin-induced rhabdomyolysis with purpura: An unrecognized interaction: A case report.

Kato K, Iwasaki Y, Onodera K, Higuchi M, Kato K, Kato Y, Tsutsui M, Taniguchi M, Furukawa H.

Int J Surg Case Rep. 2016;26:221-3. doi: 10.1016/j.ijscr.2016.07.007. Epub 2016 Jul 14.

11.

A Therapeutic Effects of Atorvastatin on Genetic Damage in Coronary Artery Disease.

Gundapaneni KK, Shyamala N, Galimudi RK, Sahu SK, Hanumanth SR.

J Clin Diagn Res. 2016 Jun;10(6):OC28-30. doi: 10.7860/JCDR/2016/19769.8038. Epub 2016 Jun 1.

12.

Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats.

Campos-Martorell M, Cano-Sarabia M, Simats A, Hernández-Guillamon M, Rosell A, Maspoch D, Montaner J.

Int J Nanomedicine. 2016 Jun 29;11:3035-48. doi: 10.2147/IJN.S107292. eCollection 2016.

13.

Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study.

Wongprikorn A, Sukasem C, Puangpetch A, Numthavej P, Thakkinstian A, Kiertiburanakul S.

PLoS One. 2016 Jun 15;11(6):e0157531. doi: 10.1371/journal.pone.0157531. eCollection 2016.

14.

HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".

Kohli P, Ganz P, Ma Y, Scherzer R, Hur S, Weigel B, Grunfeld C, Deeks S, Wasserman S, Scott R, Hsue PY.

J Am Heart Assoc. 2016 Apr 29;5(5). pii: e002683. doi: 10.1161/JAHA.115.002683.

15.

High-Density Lipoproteins for Therapeutic Delivery Systems.

Mutharasan RK, Foit L, Thaxton CS.

J Mater Chem B. 2016 Jan 14;4(2):188-197. Epub 2015 Nov 24.

16.

Statins and its hepatic effects: Newer data, implications, and changing recommendations.

Jose J.

J Pharm Bioallied Sci. 2016 Jan-Mar;8(1):23-8. doi: 10.4103/0975-7406.171699. Review.

17.

Statin adjunctive therapy shortens the duration of TB treatment in mice.

Dutta NK, Bruiners N, Pinn ML, Zimmerman MD, Prideaux B, Dartois V, Gennaro ML, Karakousis PC.

J Antimicrob Chemother. 2016 Jun;71(6):1570-7. doi: 10.1093/jac/dkw014. Epub 2016 Feb 21.

19.

Overcoming Challenges With Statin Therapy.

Spence JD, Dresser GK.

J Am Heart Assoc. 2016 Jan 27;5(1). pii: e002497. doi: 10.1161/JAHA.115.002497. Review. No abstract available.

20.

Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital.

Sangsawang T, Sriwijitkamol A.

Vasc Health Risk Manag. 2015 Nov 4;11:563-7. doi: 10.2147/VHRM.S92461. eCollection 2015.

Supplemental Content

Support Center